Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ViferaXS Logo
ViferaXS CB Rank
553223
Heat Score
68
Tailored peptide antigens and potent adjuvant formulation drive powerful and specific anti-cancer T cell immune responses.
Founded
obfuscation
Private Tübingen, Baden-Wurttemberg, Germany1-10 www.viferaxs.com
Biotechnology
Life Science
Pharmaceutical
Overview

ViferaXS
Heat Score
68

Growth Score
pts
in past quarter
Heat Score 68
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ViferaXS

CB Rank
553223
Tailored peptide antigens and potent adjuvant formulation drive powerful and specific anti-cancer T cell immune responses.
Founded
obfuscation
Private Tübingen, Baden-Wurttemberg, Germany1-10 www.viferaxs.com
Biotechnology
Life Science
Pharmaceutical

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Sezai Taskin
Contact Email info@viferaxs.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Cancer Vaccines
Therapeutic vaccines designed to elicit specific T cell immune responses against cancer using tailored peptide antigens and adjuvant formulations.
Infectious Disease Vaccines
Vaccines aimed at inducing immune responses against infectious diseases using peptide antigens and adjuvant formulations.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$363.2KThis year, ViferaXS is projected to spend $363.2K on IT, according to Aberdeen.

Active Website Tech Count

2ViferaXS is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is ViferaXS's headquarters? ViferaXS is located in Tübingen, Baden-Wurttemberg, Germany.Who are ViferaXS's competitors? Alternatives and possible competitors to ViferaXS may include Gilead Sciences, OS Therapies, and  Elicio Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|